About: A harm reduction paradox: Comparing China's policies on needle and syringe exchange and methadone maintenance

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A harm reduction paradox: Comparing China's policies on needle and syringe exchange and methadone maintenance Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	A harm reduction paradox: Comparing China's policies on needle and syringe exchange and methadone maintenance
Creator	Wang, Ning Bartlett, Nicholas Smith, Kumi
topic	covid:43ad9da868f9d2b2c6519be48b6f7fd70321df74#this
Source	Elsevier; Medline; PMC
abstract	Abstract Background China has launched methadone maintenance treatment (MMT) and needle and syringe exchange programmes (NSEP) as part of the country's HIV prevention strategy amongst injection drug users. MMT is expanding, with backing from multiple government ministries, however, NSEP have received less political support and funding. Methods Semi-structured, serial interviews were conducted with key informants, knowledgeable about China's harm reduction policies. Concurrent content analysis allowed for revision of the interview guide throughout the data collection process. This was combined with a systematic analysis of official government policy documents on NSEP and MMT, including white papers, legal documents, and policy statements. Findings Early consensus between public security and public health sectors regarding methadone's dual use in HIV prevention as well as method of drug control created broad institutional support for MMT programmes amongst policy makers. In contrast, NSEP were seen as satisfying only the HIV prevention goals of the public health sector, and were perceived as condoning illicit drug use. Furthermore, NSEP's roots in China, as an experimental collaboration with international groups, created suspicion regarding its role in China's drug control policy. NSEP and MMT's distinct paths to policy development are reflected in the complex and occasionally contradictory nature of China's harm reduction strategy. Conclusions These discrepancies highlight the need for a more politically sustainable and comprehensive integration of harm reduction projects. Recommendations include improved evaluation methods for NESP, NSEP-MMT cross-referral system, and stronger NSEP advocacy within the non-profit and public health sectors.
has issue date	2012-07-31(xsd:dateTime)
bibo:doi	10.1016/j.drugpo.2011.09.010
bibo:pmid	22377341
has license	els-covid
sha1sum (hex)	43ad9da868f9d2b2c6519be48b6f7fd70321df74
schema:url	https://doi.org/10.1016/j.drugpo.2011.09.010
resource representing a document's title	A harm reduction paradox: Comparing China's policies on needle and syringe exchange and methadone maintenance
has PubMed Central identifier	PMC7135432
has PubMed identifier	22377341
schema:publication	International Journal of Drug Policy
resource representing a document's body	covid:43ad9da868f9d2b2c6519be48b6f7fd70321df74#body_text
is http://vocab.deri.ie/void#inDataset of	proxy:http/ns.inria.fr/covid19/43ad9da868f9d2b2c6519be48b6f7fd70321df74
is schema:about of	named entity '27S' named entity 'China' named entity 'programmes' named entity 'MMT' named entity 'Background' named entity 'sustainable' named entity 'conducted' named entity 'policies' named entity 'projects' named entity 'legal documents' named entity 'interview' named entity 'security' named entity 'NEED FOR' named entity 'PREVENTION STRATEGY' named entity 'CREATED' named entity 'IMPROVED' named entity 'SUSTAINABLE' named entity 'CONCLUSIONS' named entity 'DISTINCT' named entity 'SEMI-STRUCTURED' named entity 'ADVOCACY' named entity 'PUBLIC' named entity 'INSTITUTIONAL SUPPORT' named entity 'DISCREPANCIES' named entity 'RECOMMENDATIONS' named entity '27S' named entity 'INTERVIEW' named entity 'FUNDING' named entity 'CONTRAST' named entity 'MULTIPLE' named entity 'INTERNATIONAL' named entity 'EVALUATION METHODS' named entity 'ANALYSIS' named entity 'SUPPORT' named entity 'REFERRAL' named entity 'CROSS' named entity 'NON-PROFIT' named entity 'METHADONE MAINTENANCE' named entity 'COMPREHENSIVE' named entity 'MMT' named entity 'SYRINGE' covid:arg/43ad9da868f9d2b2c6519be48b6f7fd70321df74 named entity 'POLICY' named entity 'ROLE' named entity 'ABOUT' named entity 'SYRINGE' named entity 'EXPERIMENTAL' named entity 'HARM REDUCTION' named entity 'GOVERNMENT' named entity 'COMPARING' named entity 'HARM REDUCTION' named entity 'NEEDLE' named entity 'EXCHANGE' named entity 'POLICIES' named entity 'CONSENSUS' named entity 'WHITE PAPERS' named entity 'COMBINED' named entity 'PUBLIC HEALTH' named entity 'EXPANDING' named entity 'REVISION' named entity 'METHOD' named entity 'HAVE' named entity 'MAKERS' named entity 'KNOWLEDGEABLE' named entity 'POLICIES' named entity 'ROOTS' named entity 'OFFICIAL' named entity 'POLICY DEVELOPMENT' named entity 'NESP' named entity 'STRATEGY' named entity 'COUNTRY' named entity 'NEEDLE' named entity 'EARLY' named entity 'INCLUDING' named entity 'RECEIVED' named entity 'BROAD' named entity 'CONCURRENT'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software